Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.
Eur J Med Chem
; 70: 758-67, 2013.
Article
en En
| MEDLINE
| ID: mdl-24239623
Palabras clave
2-dicyclohexylphosphino-2',4',6'-triisopropyl-biphenyl; BMK1; Benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-one; DCAMKL2; DIEA; DMA; EGF; ERK5; ERK5 inhibitor; HCC; Kinase selectivity; LRRK2; MAP kinase kinase 5; MAPK; MEK5; N,N-diisopropylethylamine; N,N-dimethylacetamide; PLK; PML; Pd(2)(dba)(3); RSK; SAR; X-phos; XVBGRTMNFNMINE-UHFFFAOYSA-N; big MAP kinase 1; doublecortin and CaM kinase-like 2; epidermal growth factor; extracelluar-signal-regulated kinase 5; hepatocellular carcinoma; leucine rich repeat kinase 2; mitogen-activated protein kinase; mitogen-activated protein kinase 7; polo-like kinase; promyelocytic leukemia protein; ribosomal S6 kinase; structureactivity relationship; tris(dibenzylideneacetone)dipalladium-(0)
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Pirimidinas
/
Azepinas
/
Proteínas Serina-Treonina Quinasas
/
Proteína Quinasa 7 Activada por Mitógenos
/
Inhibidores de Proteínas Quinasas
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Eur J Med Chem
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos